Thiazolidinediones, Peripheral Edema, and Type 2 Diabetes: Incidence, Pathophysiology, and Clinical Implications
- 1 October 2003
- journal article
- review article
- Published by Elsevier in Endocrine Practice
- Vol. 9 (5) , 406-416
- https://doi.org/10.4158/ep.9.5.406
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- New Oral Therapies for Type 2 Diabetes Mellitus: The Glitazones or Insulin SensitizersAnnual Review of Medicine, 2001
- Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: A randomized, placebo-controlled studyClinical Therapeutics, 2000
- Pulmonary Edema Associated With Troglitazone TherapyArchives of internal medicine (1960), 1999
- The effect of insulin on the vascular reactivity of isolated resistance arteries taken from healthy volunteersDiabetologia, 1995
- Nitric oxide release accounts for insulin's vascular effects in humans.Journal of Clinical Investigation, 1994
- Insulin-mediated vasodilation: impairment with increased blood pressure and body massThe Lancet, 1993
- Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans.Hypertension, 1992
- Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance.Journal of Clinical Investigation, 1990
- Insulin Oedema and its Clinical Significance: Metabolic Studies in Three CasesDiabetic Medicine, 1985
- Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites FluidScience, 1983